col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


115 Results       Page 1

 [1] 
Elsevier: Clinical Gastroenterology and Hepatology
  original article Date Title Authors   All Authors
1 [GO] 2024―Feb―16 Long-Term Effectiveness and Durability of COVID-19 Vaccination among Patients with Inflammatory Bowel Disease Erica J. Brenner, Kimberly N. Weaver, Xian Zhang, Arthur J. Kastl, Jennifer A. Strople, Jeremy Adler, et al. (+19)
2 [GO] 2024―Jan―25 Prolonged Gastrointestinal Manifestations After Recovery From COVID-19 Cong Dai, Yu-hong Huang, Min Jiang
3 [GO] 2023―Nov―22 Prolonged gastrointestinal manifestations after recovery from COVID-19 B. Joseph Elmunzer, Olafur S. Palsson, Nauzer Forbes, Ali Zakaria, Christian Davis, Andrew Canakis, et al. (+19)
4 [GO] 2023―Feb―16 Increased Risk of Hospitalization in Celiac Disease with COVID-19 Infection is Mitigated by Vaccination Andrew Ford, Arjun Chatterjee, Ruishen Lyu, John McMichael, Claire Jansson-Knodell, Alberto Rubio-Tapia
5 [GO] 2023―Jan―13 The Risk of Developing Long COVID in Patients with Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter? Arno R. Bourgonje, Antonius T. Otten
6 [GO] 2022―Dec―23 Stool-based tests mitigate impacts of COVID-19 on colorectal cancer screening Po-Hong Liu, Amit G. Singal, Caitlin C. Murphy
7 [GO] 2022―Dec―23 Incidence of Long COVID and impact of medications on the risk of developing Long COVID in a nationwide cohort of IBD patients Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
8 [GO] 2022―Oct―21 Long-term gastrointestinal sequelae following COVID-19: A prospective follow-up cohort study Rithvik Golla, Sudheer Vuyyuru, Bhaskar Kante, Peeyush Kumar, David Thomas Mathew, Govind Makharia, et al. (+2)
9 [GO] 2022―Sep―22 Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in patients with Inflammatory Bowel Disease: A Propensity Matched Study Jana G. Hashash, Aakash Desai, Gursimran S. Kochhar, Francis A. Farraye
10 [GO] 2022―Aug―25 Impact of biologics on SARS-COV-2 disease course when infused within 2 weeks of acquiring the infection among IBD patients Nabeel Khan, Manthankumar Patel, Ramaswamy Sundararajan
11 [GO] 2022―Aug―06 The COVID-19 Pandemic and Postinfection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists Walter W. Chan, Madhusudan Grover
12 [GO] 2022―Jul―16 Humoral and cellular immune response after third and fourth SARS-CoV-2 mRNA vaccination in liver transplant recipients Aenne Harberts, Golda M. Schaub, Darius F. Ruether, Paul M. Duengelhoef, Thomas T. Brehm, Hendrik Karsten, et al. (+9)
13 [GO] 2022―Jul―08 Trends in Etiology-based Mortality from Chronic Liver Disease before and during COVID-19 Pandemic in the United States Donghee Kim, Omar Alshuwaykh, Brittany B. Dennis, George Cholankeril, Aijaz Ahmed
14 [GO] 2022―Jun―16 Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis Binu V. John, A. Sidney Barritt, Andrew Moon, Tamar H. Taddei, David E. Kaplan, Bassam Dahman, et al. (+6)
15 [GO] 2022―Jun―13 Exam 1: Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis
16 [GO] 2022―Jun―10 This is in response to Letter to the Editor: “No Association Between Nonalcoholic Fatty Liver Disease and Severe COVID-19? Something We Might Ignore” by Hui Gao and Lei Xu. Jiuling Li, Wanqing Liu, Peng Chen
17 [GO] 2022―Apr―26 SARS-CoV-2 vaccine response in patients with autoimmune hepatitis Lisa Schneider, Lorenz Schubert, Florian Winkler, Petra Munda, Stefan Winkler, Selma Tobudic
18 [GO] 2022―Apr―02 No Association Between Nonalcoholic Fatty Liver Disease and Severe COVID-19? Something We Might Ignore. Hui Gao, Lei Xu
19 [GO] 2022―Mar―19 Alcohol-Associated Liver Disease Mortality Increased from 2017-2020 and Accelerated during the COVID-19 Pandemic Sasha Deutsch-Link, Yue Jiang, Anne F. Peery, Alfred S. Barritt, Ramon Bataller, Andrew M. Moon
20 [GO] 2022―Mar―08 RE: Poor response to inactivated SARS-CoV-2 vaccine in patients with chronic liver disease Jitao Wang, Jingwen Ai, Quran Zhang, Xiaolong Qi, Wenhong Zhang
21 [GO] 2022―Feb―19 Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients with IBD: A Systematic Review and Meta-Analysis Anuraag Jena, Deepak James, Anupam K. Singh, Usha Dutta, Shaji Sebastian, Vishal Sharma
22 [GO] 2022―Feb―09 Strong Response to SARS-CoV-2 Vaccine Additional Doses among Patients with Inflammatory Bowel Diseases M.D. Long, K.N. Weaver, X. Zhang, K. Chun, M.D. Kappelman, R. Watkins, et al. (+17)
23 [GO] 2022―Feb―03 Mendelian Randomization Analysis Reveals No Causal Relationship Between Nonalcoholic Fatty Liver Disease and Severe COVID-19 Jiuling Li, Aowen Tian, Haoxue Zhu, Lanlan Chen, Jianping Wen, Wanqing Liu, Peng Chen
24 [GO] 2022―Feb―03 Poor response to inactivated SARS-CoV-2 vaccine in patients with chronic liver disease Huanhuan Cao, Rong Fan
25 [GO] 2022―Jan―20 Humoral response to 2-dose BNT162b2 mRNA COVID-19 vaccination in liver transplant recipients. Maria Guarino, Ilaria Esposito, Giuseppe Portella, Valentina Cossiga, Ilaria Loperto, Raffaella Tortora, et al. (+7)
26 [GO] 2022―Jan―06 Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease Sarah Frey, Reezwana Chowdhury, Caoilfhionn M. Connolly, William A. Werbel, Dorry L. Segev, Alyssa M. Parian, et al. (+7)
27 [GO] 2021―Dec―27 Impact of SARS-CoV-2 pandemic on vascular liver diseases A. Baiges, E. Cerda, C. Amicone, L. Téllez, E. Alvarado-Tapias, A. Puente, et al. (+25)
28 [GO] 2021―Dec―23 COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation Raffi Lev-Tzion, Gili Focht, Rona Lujan, Adi Mendelovici, Chagit Friss, Shira Greenfeld, et al. (+7)
29 [GO] 2021―Dec―20 Safety and immunogenicity of SARS-CoV-2 vaccines in patients with chronic liver diseases (CHESS-NMCID 2101): A multicenter study Jingwen Ai, Jitao Wang, Dengxiang Liu, Huiling Xiang, Ying Guo, Jiaojian Lv, et al. (+58)
30 [GO] 2021―Dec―09 High but Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease Trevor L. Schell, Luke J. Richard, Katharine Tippins, Rachel K. Russ, Mary S. Hayney, Freddy Caldera
31 [GO] 2021―Oct―27 Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada Abdel Aziz Shaheen, Kristine Kong, Christopher Ma, Chelsea Doktorchik, Carla S. Coffin, Mark G. Swain, et al. (+6)
32 [GO] 2021―Oct―19 Coronavirus associated bleeding esophageal ulcerations Karan Sachdeva, Amrit K. Kamboj, David H. Bruining
33 [GO] 2021―Oct―12 Reply to COVID-19 morbidity and severity in patients with non-alcoholic fatty liver disease in South Korea: a nationwide cohort study Liping Chen, Zhenyu Fan, Jilin Cheng
34 [GO] 2021―Sep―09 SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients Darius F. Ruether, Golda M. Schaub, Paul M. Duengelhoef, Friedrich Haag, Thomas T. Brehm, Anahita Fathi, et al. (+10)
35 [GO] 2021―Sep―02 Increased hepatic expression of SARS-CoV-2 entry points and pro-inflammatory cytokines in cirrhosis Nathaly Limon-de la Rosa, Eduardo Cervantes-Alvarez, Nalu Navarro-Alvarez
36 [GO] 2021―Aug―12 COVID-19 mortality- The culprit may not be proton pump inhibitors Zhihui Duan, Shengyun Zhou, Xiaofang Sun
37 [GO] 2021―Jul―24 COVID-19 morbidity and severity in patients with non-alcoholic fatty liver disease in South Korea: a nationwide cohort study Hae Won Yoo, Jae Il Shin, Dong Keon Yon, Seung Won Lee
38 [GO] 2021―Jul―10 Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, before and during COVID-19 Pandemic Donghee Kim, Clark Andrew Bonham, Peter Konyn, George Cholankeril, Aijaz Ahmed
39 [GO] 2021―Jul―01 Gastrointestinal sequelae three and six months after hospitalization for Coronavirus Disease 2019 Anam Rizvi, Zankesh Patel, Yan Liu, Sanjaya K. Satapathy, Keith Sultan, Arvind J. Trindade
40 [GO] 2021―Jun―17 An International Reporting Registry of Patients with Celiac Disease and COVID-19: Initial Results from SECURE-CELIAC Eugenia Uche-Anya, Steffen Husby, Gilaad G. Kaplan, Fox E. Underwood, Peter HR. Green, Benjamin Lebwohl
41 [GO] 2021―Jun―05 No durable impact of COVID-19 on intestinal disease activity in subjects with IBD Dana Lukin, Gabriela Funez-dePagnier, Svetlana Lima, Daniel Lai, Lucia Duenas-Bianchi, Waseem Ahmed, et al. (+4)
42 [GO] 2021―Jun―02 COVID-19 outcomes among racial and ethnic minority individuals with inflammatory bowel disease in the United States Manasi Agrawal, Erica J. Brenner, Joyce Wing Yan Mak, Xian Zhang, Gilaad G. Kaplan, Siew C. Ng, et al. (+8)
43 [GO] 2021―May―21 Liver injury in severe COVID-19 disease - Need a closer look! Ankur Jindal
44 [GO] 2021―May―15 Significant liver injury during hospitalization for COVID-19 is not associated with liver insufficiency or death Michael Chew, Zeyu Tang, Christopher Radcliffe, Dennis Caruana, Natty Doilicho, Maria M. Ciarleglio, et al. (+2)
45 [GO] 2021―May―14 SARS-CoV-2 Induced Pancreatitis is a Rare but Real Entity Sumant Inamdar, Arvind J. Trindade
46 [GO] 2021―May―11 Increased Diagnosis of Hepatocellular Carcinoma in Hospitalized Patients with Alcohol Related Hepatitis after the Covid-19 Outbreak: A Global Multi-Center Propensity Matched Analysis Abhilash Perisetti, Randeep Kaur, Ragesh Thandassery
47 [GO] 2021―May―11 Proton pump inhibitor use is not strongly associated with SARS-CoV-2 related outcomes: A nationwide study and meta-analysis Simone Bastrup Israelsen, Martin Thomsen Ernst, Andreas Lundh, Lene Fogt Lundbo, Håkon Sandholdt, Jesper Hallas, Thomas Benfield
48 [GO] 2021―Apr―19 Serum Lipase Elevations in COVID-19 Patients Reflect Critical Illness and not Acute Pancreatitis Mitchell L. Ramsey, B Joseph Elmunzer, Somashekar G. Krishna
49 [GO] 2021―Apr―03 An Impetus for Change: How COVID-19 Will Transform the Delivery of GI Healthcare David A. Leiman, Michael L. Weinstein, Megan A. Adams
50 [GO] 2021―Mar―14 Hepatic injury and repair patterns in fatal COVID-19: consequences for outcome subsequent to liver transplantation Martin Krüger, Simon C. Robson, Jan Schulte am Esch
51 [GO] 2021―Feb―10 Liver injury in liver transplant patients with COVID-19: a histopathological confirmation Alexander Ng
52 [GO] 2021―Feb―05 COVID-19 vaccination intent and perceptions among patients with inflammatory bowel diseases Rahul S. Dalal, Emma McClure, Jenna Marcus, Rachel W. Winter, Matthew J. Hamilton, Jessica R. Allegretti
53 [GO] 2021―Feb―05 What Gastroenterologists Should Know About COVID-19 Vaccines Stacey Rolak, Mary S. Hayney, Francis A. Farraye, Jonathan L. Temte, Freddy Caldera
54 [GO] 2021―Jan―29 Hepatic vasculopathy and regenerative responses of the liver in fatal cases of COVID-19 Barbara Kaltschmidt, Antonia D.E. Fitzek, Julia Schaedler, Christine Förster, Christian Kaltschmidt, Thorsten Hansen, et al. (+14)
55 [GO] 2020―Dec―29 Seeking Health Care During COVID-19
56 [GO] 2020―Dec―25 Pediatric and adult patients diagnosed with celiac disease are not at higher risk of contracting SARS-CoV-2 (COVID-19). M Ines Pinto-Sanchez, Elena F. Verdu
57 [GO] 2020―Dec―03 Prevalence of COVID-19 in Italian children with celiac disease: a cross-sectional study. Elena Lionetti, Andrea Fabbrizi, Carlo Catassi
58 [GO] 2020―Dec―03 Psychological Health Among Gastroenterologists During the COVID-19 Pandemic: A National Survey Eric D. Shah, Mohsen Pourmorteza, B. Joseph Elmunzer, Sarah K. Ballou, Georgios I. Papachristou, Luis F. Lara, et al. (+4)
59 [GO] 2020―Nov―20 C.O.V.I.D.: A Survival Guide for GI Fellowship Training During the COVID-19 Pandemic Tzu-Hao Lee, Cecelia Zhang, Richard Wood, Darshan Kothari
60 [GO] 2020―Oct―15 COVID-19 Epidemiology and Google Searches Claire L. Jansson-Knodell, Indira Bhavsar-Burke, Andrea Shin
61 [GO] 2020―Oct―12 THE RISK OF CONTRACTING COVID-19 IS NOT INCREASED IN PATIENTS WITH CELIAC DISEASE J. Zhen, J.P. Stefanolo, M.P. Temprano, S. Tedesco, C. Seiler, A. Caminero, et al. (+20)
62 [GO] 2020―Oct―12 Diffuse Hemorrhagic Enterocolitis in the setting of 2019 Coronavirus Blanca Lizaola-Mayo, Marcela Salomao, Jennifer L. Horsley-Silva
63 [GO] 2020―Oct―12 BENIGN EVOLUTION OF SARS-CoV2 INFECTIONS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM TWO INTERNATIONAL DATABASES Erica J. Brenner, Bénédicte Pigneur, Gili Focht, Xian Zhang, Ryan C. Ungaro, Jean-Frederic Colombel, et al. (+3)
64 [GO] 2020―Oct―01 Digestive Manifestations in Patients Hospitalized with COVID-19 B. Joseph Elmunzer, Rebecca L. Spitzer, Lydia D. Foster, Ambreen A. Merchant, Eric F. Howard, Vaishali A. Patel, et al. (+119)
65 [GO] 2020―Sep―30 Disease Course and Outcomes of COVID-19 Among Hospitalized Patients with Gastrointestinal Manifestations Monika Laszkowska, Adam S. Faye, Judith Kim, Han Truong, Elisabeth R. Silver, Myles Ingram, et al. (+9)
66 [GO] 2020―Sep―24 Reducing the Risk of Vaccine Preventable Diseases During the COVID-19 Pandemic Megan Lutz, Mary S. Hayney, Francis A. Farraye, Freddy Caldera
67 [GO] 2020―Sep―17 Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study Donghee Kim, Nia Adeniji, Nyann Latt, Sonal Kumar, Patricia P. Bloom, Elizabeth S. Aby, et al. (+25)
68 [GO] 2020―Sep―06 Impact of SARS-CoV-2 pandemic on colorectal cancer screening delay: effect on stage shift and increased mortality Luigi Ricciardiello, Clarissa Ferrari, Michela Cameletti, Federica Gaiani, Francesco Buttitta, Franco Bazzoli, et al. (+3)
69 [GO] 2020―Aug―18 IBD patients with COVID-19: the picture is taking shape. Alfredo PAPA, Loris Riccardo Lopetuso, Antonio Tursi
70 [GO] 2020―Aug―11 Clinical outcomes of COVID-19 patients with chronic hepatitis B virus infection still need to be explored Xiu-He Lv, Jin-Lin Yang, Kai Deng
71 [GO] 2020―Aug―08 Systematic review on IBD patients with COVID-19: it is time to take stock Ferdinando D’Amico, Silvio Danese, Laurent Peyrin-Biroulet
72 [GO] 2020―Aug―04 Liver function should be monitored when treating COVID-19 in chronic HBV-infected patients Xiaojing Zou, Minghao Fang, Jiao Huang
73 [GO] 2020―Jul―25 Hepatic disorders with the use of remdesivir for coronavirus 2019 (COVID-19) François Montastruc, Samuel Thuriot, Geneviève Durrieu
74 [GO] 2020―Jul―23 Letter to the Editor: Lessons from COVID-19, ACE2 and intestinal inflammation - could a virus trigger chronic intestinal inflammation? Timothy P. Hanrahan, John S. Lubel, Mayur Garg
75 [GO] 2020―Jul―18 Exam 2: Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy
76 [GO] 2020―Jul―11 Gastroenterologists and Patients Report High Satisfaction Rates with Telehealth Services during the Novel Coronavirus 2019 (COVID-19) Pandemic Avi Dobrusin, Fadi Hawa, Mark Gladshteyn, Paul Corsello, Kevin Harlen, Charlie Walsh, et al. (+5)
77 [GO] 2020―Jul―10 Reply to Clinical characteristics of COVID-19 in patients with liver injury Liping Chen, Zhenyu Fan, Jilin Cheng
78 [GO] 2020―Jul―08 Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic Neil Mehta, Neehar Parikh, R Katie Kelley, Bilal Hameed, Amit G. Singal
79 [GO] 2020―Jul―04 Increased internet search interest for GI symptoms may predict COVID-19 cases in US hotspots Imama Ahmad, Ryan Flanagan, Kyle Staller
80 [GO] 2020―Jun―17 SARS-CoV-2-related Hypercoagulable State Leading to Ischemic Enteritis Secondary to Superior Mesenteric Artery Thrombosis James Michael Mitchell, Dinesh Rakheja, Purva Gopal
81 [GO] 2020―Jun―16 Clinical features and outcomes of coronavirus disease 2019 (COVID-19) patients with chronic Hepatitis B virus infection Bin Zhang, Wenhui Huang, Shuixing Zhang
82 [GO] 2020―Jun―15 Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV co-infection Xiaojing Zou, Minghao Fang, Shusheng Li, Liang Wu, Bing Gao, Hong Gao, et al. (+7)
83 [GO] 2020―Jun―12 Putative Mechanisms of diarrhea in COVID-19 Abhilash Perisetti, Mahesh Gajendran, Hemant Goyal
84 [GO] 2020―Jun―10 Detection of SARS-CoV-2 in Fecal Samples from Patients with Asymptomatic and Mild COVID-19 in Korea Soo-kyung Park, Chil-Woo Lee, Dong-Il Park, Hee-Yeon Woo, Hae Suk Cheong, Ho Cheol Shin, et al. (+3)
85 [GO] 2020―Jun―06 Covid-19 and inflammatory bowel disease: questions on incidence, severity, and impact of treatment? Bénédicte Caron, Yves Arondel, Jean-Marie Reimund
86 [GO] 2020―Jun―01 Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 patients in Queens, NY Samson Ferm, Constantine Fisher, Tina Pakala, Michelle Tong, Disha Shah, David Schwarzbaum, et al. (+3)
87 [GO] 2020―May―30 Pneumatosis Intestinalis in COVID-19 Seetha Lakshmanan, Nabil Toubia
88 [GO] 2020―May―30 Follow your Gut: Challenges in Nutritional Therapy during the COVID-19 Pandemic Enrik John T. Aguila, Marie Antoinette, Carlos Paolo D. Francisco
89 [GO] 2020―May―30 ENDOSCOPIC FINDINGS IN PATIENTS INFECTED WITH 2019 NOVEL CORONAVIRUS IN LOMBARDY, ITALY Sara Massironi, Chiara Viganò, Lorenzo Dioscoridi, Elisabetta Filippi, Michela Pagliarulo, Guido Manfredi, et al. (+16)
90 [GO] 2020―May―30 Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study Cristina Rigamonti, Micol Giulia Cittone, Carla De Benedittis, Eleonora Rizzi, Giuseppe Francesco Casciaro, Mattia Bellan, et al. (+2)
91 [GO] 2020―May―22 Plans to Reactivate Gastroenterology Practices Following the COVID-19 Pandemic: A Survey of North American Centers Vladimir M. Kushnir, Tyler M. Berzin, B. Joseph Elmunzer, Robin B. Mendelsohn, Vaishali Patel, Swati Pawa, et al. (+2)
92 [GO] 2020―May―17 COVID-19 related liver injury: call for international consensus Zheng Ye, Bin Song
93 [GO] 2020―May―16 We know liver biochemistries are elevated in COVID-19, but should we be concerned? Patricia P. Bloom, Trisha S. Pasricha, Kathleen Viveiros
94 [GO] 2020―May―16 Pooled Prevalence of Diarrhea among COVID-19 Patients Rhuvi Villamizar-Peña, Estefanía Gutiérrez-Ocampo, Alfonso J. Rodríguez-Morales.
95 [GO] 2020―May―12 COVID-19: an overview of worldwide recommendations for management of patients with liver diseases or liver transplantation Hugo Perazzo, Juliana Piedade, Rodolfo Castro, Laura Pinto, Valdiléa G. Veloso, Beatriz Grinsztejn, et al. (+2)
96 [GO] 2020―May―12 Keeping on the high quality of healthcare in Greek Inflammatory Bowel Disease patients in the SARS-CoV-2 era Kalliopi Foteinogiannopoulou, Eleni Orfanoudaki, Ioannis E. Koutroubakis
97 [GO] 2020―May―11 Covid-19 digestive system involvement and clinical outcomes in a large academic hospital in Milan, Italy. Alessio Aghemo, Daniele Piovani, Tommaso Lorenzo Parigi, Enrico Brunetta, Nicola Pugliese, Edoardo Vespa, et al. (+9)
98 [GO] 2020―May―11 Clinical Characteristics of COVID-19 in Patients With Liver Injury Peng Chen, Benhong Zhou
99 [GO] 2020―May―11 Cardiac and Muscle Injury Might Partially Contribute to Elevated Aminotransferases in COVID-19 Patients Yongxing Xu, Jianwen Gu
100 [GO] 2020―May―07 Gastroenterologists, Hepatologists, COVID-19 and the Use of Acetaminophen Alfonso J. Rodríguez-Morales, Jaime A. Cardona-Ospina, Maria Mónica Murillo-Muñoz
101 [GO] 2020―May―05 Managing Inflammatory Bowel Disease During COVID-19: Summary of Recommendations from Gastrointestinal Societies Jurij Hanzel, Christopher Ma, John K. Marshall, Brian G. Feagan, Vipul Jairath
102 [GO] 2020―May―03 RECOMMENDATIONS FOR ESSENTIAL ESOPHAGEAL PHYSIOLOGICTESTING DURING THE COVID-19 PANDEMIC Yeong Yeh Lee, Albert J. Bredenoord, C. Prakash Gyawali
103 [GO] 2020―May―01 The topic of COVID-19 related liver injury needs more rigorous research Xiu-He Lv, Jin-Lin Yang, Kai Deng
104 [GO] 2020―Apr―30 Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts Mariangela Allocca, Gionata Fiorino, Camille Zallot, Federica Furfaro, Daniela Gilardi, Simona Radice, et al. (+2)
105 [GO] 2020―Apr―23 Current Knowledge and Research Priorities in the Digestive Manifestations of COVID-19 Olga C. Aroniadis, Christopher J. DiMaio, Rebekah E. Dixon, B. Joseph Elmunzer, Jennifer M. Kolb, Robin Mendelsohn, et al. (+7)
106 [GO] 2020―Apr―23 HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN Maria Francesca Donato, Federica Invernizzi, Pietro Lampertico, Giorgio Rossi
107 [GO] 2020―Apr―23 ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection Furong Liu, Xin Long, Bixiang Zhang, Wanguang Zhang, Xiaoping Chen, Zhanguo Zhang
108 [GO] 2020―Apr―22 Donning a new approach to the practice of gastroenterology: perspectives from the COVID-19 pandemic epicenter Amrita Sethi, Arun Swaminath, Melissa Latorre, Daniel S. Behin, Daniela Jodorkovsky, Delia Calo, et al. (+11)
109 [GO] 2020―Apr―18 Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19 Xiao-Shan Wei, Xu Wang, Yi-Ran Niu, Lin-Lin Ye, Wen-Bei Peng, Zi-Hao Wang, et al. (+6)
110 [GO] 2020―Apr―15 Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic Mariangela Allocca, Gionata Fiorino, Federica Furfaro, Daniela Gilardi, Simona Radice, Ferdinando D’Amico, et al. (+2)
111 [GO] 2020―Apr―11 Clinical Features of COVID-19-Related Liver Damage Zhenyu Fan, Liping Chen, Jun Li, Xin Cheng, Cheng Tian, Yajun Zhang, et al. (+3)
112 [GO] 2020―Apr―08 Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management Ferdinando D’Amico, Daniel C. Baumgart, Silvio Danese, Laurent Peyrin-Biroulet
113 [GO] 2020―Mar―30 Will the quality of research remain the same during the COVID-19 pandemic? Laurent Peyrin-Biroulet
114 [GO] 2020―Mar―20 Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19) Shihua Luo, Xiaochun Zhang, Haibo Xu
115 [GO] 2020―Mar―18 What Should Gastroenterologists and Patients Know About COVID-19? Ryan C. Ungaro, Timothy Sullivan, Jean-Frederic Colombel, Gopi Patel
 [1] 

115 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec